Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 27th Prioritisation – 2nd quarter 2016 . HSO: 27th Prioritisation.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
548kB |
Abstract
For the 27th prioritisation (June 2016), 12 drugs were filtered out of 282 identified and were sent to prioritisation. Of these, 5 drugs were ranked as 'highly relevant' by the expert panel, 7 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
Item Type: | DSD: Horizon Scanning in Oncology |
---|---|
Subjects: | WB Practice of medicine > WB 300-962 Therapeutics QZ Pathology > QZ 200-380 Neoplasms.Cysts QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology |
Language: | English |
Series Name: | HSO: 27th Prioritisation |
Deposited on: | 05 Aug 2016 17:52 |
Last Modified: | 15 Jul 2020 17:54 |
Repository Staff Only: item control page